Jason O'Byrne - EVP & Chief Financial Officer at Vir Biotechnology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP & Chief Financial Officer
Stock Symbol
VIR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jason O'Byrne since 12/25/2023

Holdings reported by Jason O'Byrne for Vir Biotechnology, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 75K $758K $10.11 Nov 15, 2024 Direct
Stock Option (Right to Buy) 150K $230K $1.53 Nov 15, 2024 Direct Common Stock

Transactions reported by Jason O'Byrne for Vir Biotechnology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.